Comparison of selective retinoic acid receptor– and retinoic X receptor–mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma
- 31 July 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (1) , 25-32
- https://doi.org/10.1016/j.jaad.2003.11.058
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mechanism of Selective Retinoid X Receptor Agonist-Induced Hypothyroidism in the RatEndocrinology, 2002
- Retinoic acid–induced apoptotic pathway in T-cell lymphomaExperimental Hematology, 2000
- Retinoids Synergize with Interleukin-2 to Augment IFN-gamma and Interleukin-12 Production by Human Peripheral Blood Mononuclear CellsJournal of Interferon & Cytokine Research, 1999
- Treatment of early AIDS-related Kaposiʼs sarcoma with oral all-trans-retinoic acidAIDS, 1998
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995
- Roferon-A in Combination with Tigason in Cutaneous T-Cell LymphomasActa Haematologica, 1993
- Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)Journal of the American Academy of Dermatology, 1992
- The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-α2a and etretinateBritish Journal of Dermatology, 1991
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Treatment of cutaneous lymphoma with etretinateBritish Journal of Dermatology, 1983